Central Trust Company’s SkinHealth Systems SKIN Stock Holding History

Central Trust Company’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21	Closed	–	–	1407
2022 Q2	$0	Hold	21	–	–	﹤0.01%	1447
2022 Q1	$0	Buy	+21	New	+$347	﹤0.01%	1471

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Central Trust Company's SKIN Position: Q3 2022 in Review

Central Trust Company sold out of SkinHealth Systems (SKIN) in Q3 2022, closing a stake of 21 shares.

Central Trust Company first reported a position in SKIN in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 167 funds tracked by Wall St. Rank hold SKIN as of Q3 2022.

Central Trust Company reported no remaining SkinHealth Systems position as of Q3 2022 after selling out during the quarter.
Central Trust Company sold 21 SkinHealth Systems shares in Q3 2022.
Central Trust Company first reported a position in SkinHealth Systems in Q1 2022 and held it in 2 quarters.
Central Trust Company's SkinHealth Systems position peaked at $0 in Q2 2022.
167 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2022.

Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.